Idiopathic focal segmental glomerulosclerosis: A favourable prognosis in untreated patients?

Netherlands Journal of Medicine

Volumn 63, Issue 10, 2005, Pages 393-398

  Deegens, J K J ^a   Assmann, K J M ^a   Steenbergen, E J ^a   Hilbrands, L B ^a   Gerlag, P G G ^b   Jansen, J L J ^c   Wetzels, J F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Idiopathic focal segmental glomerulosclerosis; Immunosuppression; Remission; Renal survival; Steroid treatment

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOCAL GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MALE; PROGNOSIS; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 28444463573     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Haas M, Meehan S, Karrison T, Spargo B. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997;30:621-31.
2. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA, Germain MJ. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000;35:878-83.
3. Korbet S. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 1998;9:1333-40.
4. Rydell J, Korbet S, Borok R, Schwartz M. Focal segmental glomerulosclerosis in adults: Presentation, course and response to treatment. Am J Kidney Dis 1995;25:534-42.
5. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 1987;82:938-44.
6. Korbet S, Schwartz M, Lewis EJ. The prognosis of focal segmental glomerulosclerosis of adulthood. Medicine 1986;65:304-11.
7. Ponticelli C. Focal segmental glomerulosclerosis: to treat or not to treat? 1. It is worthwhile to give the adult patient with nephrotic syndrome the benefit of an adequate therapeutic trial? Nephrol Dial Transplant 1995;10:2351-4.
8. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 1991;36:53-9.
9. Cameron JS. The enigma of focal segmental glomerulosclerosis. Kidney Int Suppl 1996;S57:119-31.
10. Schmidt A, Mayer G. The diagnostic trash bin of focal and segmental glomerulosclerosis -an effort to provide rational clinical guidelines. Nephrol Dial Transplant 1999;14:550-2.
11. Boute N, Gribouval O, Benessy F, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000;24:349-54.
12. Kaplan J, Kim S, North K, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24:251-6.
13. Chitalia V, Wells J, Robson R, Searle M, Lynn K. Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney Int 1998;56:2236-42.
14. D'Agati V, Fogo A, Bruijn J, Jennette J. Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 2004;43:368-82.
15. Bazzi C, Petrini C, Rizza V, et al. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: A pilot study. Am J Kidney Dis 2003;41:328-35.
16. Cattran D, Rao P. Long term outcome of children and adults with classic focal and segmental glomerulosclerosis. Am J Kidney Dis 1998;32:72-9.
17. Alexopoulos E, Stangou M, Papagianni A, Pantzaki A, Papadimitriou M. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000;15:1348-56.
18. Cameron JS. The long term prognosis of patients with focal glomerulosclerosis. Clin Nephrol 1978;10:213-29.
19. Caridi G, Bertelli R, Carrea A, et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 2001;12:2742-6.
20. Karle S, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002;13:388-93.
21. Korbet S. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin Nephrol 2003;23:229-33.
22. Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 2004;65:1690-702.
23. Howie AJ, Pankhurst T, Sarioglu S, Turhan N, Adu D. Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int 2005;67:987-1001.